Pyridoxine

CAS No. 65-23-6

Pyridoxine( —— )

Catalog No. M15477 CAS No. 65-23-6

Pyridoxine is the 4-methanol form of vitamin B6 and is converted to pyridoxal 5-phosphate in the body.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 35 In Stock
500MG 82 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pyridoxine
  • Note
    Research use only, not for human use.
  • Brief Description
    Pyridoxine is the 4-methanol form of vitamin B6 and is converted to pyridoxal 5-phosphate in the body.
  • Description
    Pyridoxine is the 4-methanol form of vitamin B6 and is converted to pyridoxal 5-phosphate in the body. Although pyridoxine and vitamin B6 are still frequently used as synonyms, especially by medical researchers, this practice is erroneous and sometimes misleading. (In Vitro):Pyridoxine exerts a protective potential against AD, attenuates ROS levels, decreases the expressions of cytoplasmic Nrf2, and upregulates whole-cell HO-1 expression.
  • In Vitro
    Pyridoxine exerts a protective potential against AD, attenuates ROS levels, decreases the expressions of cytoplasmic Nrf2, and upregulates whole-cell HO-1 expression.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PLK
  • Recptor
    PLK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    65-23-6
  • Formula Weight
    169.18
  • Molecular Formula
    C8H11NO3
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in Water
  • SMILES
    CC1=NC=C(CO)C(CO)=C1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Adams JB, et al. J Altern Complement Med. 2006 Jan-Feb;12(1):59-63.
molnova catalog
related products
  • TAK-960

    TAK-960 is an orally bioavailable selective inhibitor of Plks with IC50 values of 0.8 16.9 and 50.2 nM for Plk1 Plk2 and Plk3 respectively.

  • Epimedin A

    Epimedin A has anti-osteoporosis activities in vivo.

  • GW843682X

    GW843682X is effective on inhibition of growth of tumor cells, with IC50s of 0.41, 0.57, 0.11, 0.38, and 0.70 μM for A549, BT474, HeLa, H460 and HCT116 cell lines.